Product NDC: | 0093-5049 |
Proprietary Name: | Pioglitazone and Metformin Hydrocholride |
Non Proprietary Name: | pioglitazone and metformin hydrochloride |
Active Ingredient(s): | 500; 15 mg/1; mg/1 & nbsp; pioglitazone and metformin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-5049 |
Labeler Name: | Teva Pharmaceuticals USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021842 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120817 |
Package NDC: | 0093-5049-86 |
Package Description: | 180 TABLET, FILM COATED in 1 BOTTLE (0093-5049-86) |
NDC Code | 0093-5049-86 |
Proprietary Name | Pioglitazone and Metformin Hydrocholride |
Package Description | 180 TABLET, FILM COATED in 1 BOTTLE (0093-5049-86) |
Product NDC | 0093-5049 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pioglitazone and metformin hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120817 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Teva Pharmaceuticals USA |
Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
Strength Number | 500; 15 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |